ALGS logo

Aligos Therapeutics (ALGS) Enterprise Value

Enterprise Value

$69.31 M
-$3.70 M-5.06%

42 min ago


Summary


Performance

ALGS Enterprise Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherALGSvaluationmetrics:

Enterprise Value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

ALGS Enterprise Value Trends

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday-5.1%-3.7%-3.7%
1 m1 month-44.2%-36.5%-36.5%
3 m3 months+748.0%+177.9%+177.9%
6 m6 months+734.5%+119.3%+95.4%
ytdytd-37.3%-30.2%-30.2%
1 y1 year+195.3%+84.3%+54.3%
5 y5 years---

ALGS Enterprise Value Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-44.2%$59 M+17.7%
3 m3-month$140 M-50.5%$8.17 M+748.0%
6 m6-month$140 M-50.5%-$10 M+772.2%
1 y1-year$140 M-50.5%-$77 M+190.4%
3 y3-year$140 M-50.5%-$84 M+182.9%
5 y5-year$1.23 B-94.4%-$84 M+182.9%
alltimeall time$1.23 B-94.4%-$84 M+182.9%

Aligos Therapeutics Enterprise Value History

DateValue
2025
$69.31 M(-37.3%)
2024
$110.61 M(-248.1%)
2023
-$74.70 M(+168.1%)
DateValue
2022
-$27.87 M(-108.3%)
2021
$334.37 M(-58.5%)
2020
$804.75 M

FAQ

  • What is Aligos Therapeutics enterprise value?
  • What is the all time high enterprise value for Aligos Therapeutics?
  • What is ALGS enterprise value year-to-date change?
  • What is Aligos Therapeutics enterprise value year-on-year change?

What is Aligos Therapeutics enterprise value?

The current enterprise value of ALGS is $69.31 M

What is the all time high enterprise value for Aligos Therapeutics?

Aligos Therapeutics all-time high enterprise value is $1.23 B

What is ALGS enterprise value year-to-date change?

Aligos Therapeutics enterprise value has changed by -$41.30 M (-37.34%) since the beginning of the year

What is Aligos Therapeutics enterprise value year-on-year change?

Over the past year, ALGS enterprise value has changed by +$142.06 M (+195.28%)